Showing results (1-10 of 3,385) with videos related to
Sort By:
Pageof 339
Future Medicinal Chemistry|November 1, 2022
Advances in nonclassical phenyl bioisosteres for drug structural optimizationHe Li, Yali Gao, Junjie MaRSC Medicinal Chemistry|February 10, 2023
Advances in research on 3C-like protease (3CL<sup>pro</sup>) inhibitors against SARS-CoV-2 since 2020Roufen Chen, Yali Gao, Han Liu, et al.ACS Medicinal Chemistry Letters|April 17, 2024
Design, Synthesis, and Evaluation of 8-(<i>o</i>-Tolyl)quinazoline Derivatives as Small-Molecule PD-1/PD-L1 AntagonistsXingye Wu, He Li, Han Liu, et al.Molecular Diversity|May 11, 2024
Design, synthesis and biological evaluation of 5H-[1,2,4]triazino[5,6-b]indole derivatives bearing a pyridinocycloalkyl moiety as iron chelatorsHe Li, Yali Gao, Xin Ni, et al.Chemical & Pharmaceutical Bulletin|January 25, 2019
Semicarbazone Derivatives Bearing Phenyl Moiety: Synthesis, Anticancer Activity, Cell Cycle, Apoptosis-Inducing and Metabolic Stability StudyJunjie Ma, Xin Ni, Yali Gao, et al.European Journal of Medicinal Chemistry|November 29, 2021
Discovery of quinazoline derivatives as novel small-molecule inhibitors targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interactionYu Wang, Kun Huang, Yali Gao, et al.Medchemcomm|April 25, 2019
Identification and biological evaluation of novel benzothiazole derivatives bearing a pyridine-semicarbazone moiety as apoptosis inducers <i>via</i> activation of procaspase-3 to caspase-3Junjie Ma, Xin Ni, Yali Gao, et al.Journal of Computer-Aided Molecular Design|July 18, 2025
Design, synthesis, evaluation and molecular modeling of quinazoline derivatives bearing amino acids as small-molecule PD-L1 inhibitorsHan Liu, Roufen Chen, Dandan Yuan, et al.RSC Advances|September 29, 2023
Design, synthesis and biological evaluation of VEGFR-2/HDAC dual inhibitors as multitargeted antitumor agents based on fruquintinib and vorinostatYali Gao, Fei Li, Xin Ni, et al.Cancer Cell International|July 20, 2019
Long non-coding RNA MEG3 inhibits cervical cancer cell growth by promoting degradation of P-STAT3 protein via ubiquitinationJun Zhang, Yali GaoPageof 339